New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early detection.

A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

Dr. Kurt N. Ransohoff, President, Sutter Health Greater Central Coast, moderated the multidisciplinary panel of six ...

Medicus Pharma is advancing Teverelix, a recently acquired, clinical stage asset, designed to address limitations of current ...

Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Black men choose aggressive prostate cancer treatment—regardless of anticipated life expectancy—more often than Hispanic or ...

Amid his blood clot recovery, Roker was hospitalized again in December 2022 due to medical “complications.” He made his triumphant return to Today the following month. Additionally, Roker missed ...